A cholesterol profile is a blood test, not a diagnosis by itself. It reports total cholesterol, LDL, HDL, and triglycerides. LDL is the fraction that treatment usually aims to lower, because it is the one most clearly tied to cholesterol building up in artery walls. A single result can be repeated. What happens next depends on how high the LDL is, and on the rest of a person's risk, not on whether they feel any different.
A very high LDL is treated on its own
When LDL is 190 mg/dL (about 4.9 mmol/L) or higher, current guidance recommends a statin at the highest dose that can be tolerated, without waiting for a 10-year risk score. That level can run in families. It is a reason for a proper clinic review, including a repeat blood test, rather than a home remedy or a supplement. Below that level, the same number can lead to different advice in two different people.
The LDL number starts the conversation. Age, blood pressure, diabetes, and smoking decide how firmly a statin is recommended.
For most adults, the risk estimate matters
For adults without known heart disease whose LDL sits between 70 and 189 mg/dL, the American Heart Association's patient guidance on the PREVENT equations says a statin may be recommended when the estimated chance of a heart attack or stroke over 10 years is in the borderline range, from 3 percent to just under 5 percent, the intermediate range, from 5 percent to just under 10 percent, or 10 percent and higher. The recommendation is stronger as that estimate rises. A moderate-intensity statin is reasonable at borderline risk. At least a moderate-intensity statin is recommended at intermediate risk. A high-intensity statin is recommended when the 10-year estimate is 10 percent or higher.
Some adults aged 30 to 59 have a low 10-year estimate and still have a long stretch of life in which cholesterol can accumulate. In that group, a moderate-intensity statin is reasonable when LDL is 160 to 189 mg/dL (about 4.1 to 4.9 mmol/L), or when the 30-year risk is 10 percent or higher. If both the LDL and the 30-year risk are lower, the emphasis is on food, activity, weight, and not smoking.
- LDL of 190 mg/dL or higher: a statin is recommended without a 10-year score
- 10-year risk of 10 percent or higher: a high-intensity statin is recommended
- 10-year risk from 5 percent to just under 10 percent: at least a moderate-intensity statin is recommended
- 10-year risk from 3 percent to just under 5 percent: a moderate-intensity statin is reasonable, after a discussion
- Ages 30 to 59 with a low 10-year risk: a moderate-intensity statin is reasonable if LDL is 160 to 189 mg/dL, or if the 30-year risk is 10 percent or higher
Food still matters, and it is not a substitute
An eating pattern built around vegetables, fruit, whole grains, fish, and less saturated fat lowers LDL and is recommended whether or not a tablet is used. It does not replace a statin when the risk calculation says one is indicated. The American Heart Association also says dietary supplements are not recommended for lowering cholesterol, and they can interact with prescribed medicines. A statin is usually the first tablet. If LDL has not fallen enough on the highest tolerated dose, ezetimibe, and in some people a PCSK9 inhibitor, can be added. Those are decisions for the clinic, based on the remaining LDL and the risk category.
The blood test is repeated after a statin is started or the dose is changed, so the clinician can see how much the LDL has fallen. Muscle aches should be reported. They are a reason to review the dose or the drug, not a reason to stop quietly. Feeling well is the expected result. The medicine is there to lower the chance of a future heart attack or stroke, not to treat a symptom you can feel. After a heart attack or a stent, a statin is usual even when the LDL was never extremely high. That follow-up is a separate plan from a first prescription in someone who has never had heart disease.
Your questions, answered
Often the decision is the 10-year risk, not the LDL alone. A mildly raised LDL with high blood pressure, diabetes, or a higher risk estimate can still lead to a statin. An LDL of 190 mg/dL or higher is treated with a statin even when the short-term risk looks low.
